Cargando…
A case of large-cell lung carcinoma successfully treated with pembrolizumab but complicated with cholangitis
Large-cell carcinoma (LCC) of the lung is defined as an undifferentiated non-small cell lung cancer (NSCLC) and accounts for approximately 7.5% of lung cancers. Immune checkpoint inhibitors (ICIs) may be effective for LCC, but there has been no firm evidence due to its low frequency. We herein repor...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481563/ https://www.ncbi.nlm.nih.gov/pubmed/32944497 http://dx.doi.org/10.1016/j.rmcr.2020.101197 |